Establishment of a New Myeloid Cell Line with i(17q) as the Sole Chromosomal Anomaly from the Bone Marrow of a Patient with Myelodysplastic Syndrome

Acta Medica Okayama

Volumn 51, Issue 4, 1997, Pages 227-232

  Mizobuchi, Noriko ^a   Takahashi, Isao ^a,b   Horimi, Tadashi ^a,b   Yamamoto, Megumi ^a   Hamada, Kyoko ^b   Yorimitsu, Seiichi ^b   Kubonishi, Ichiro ^c  

^a CANCER INSTITUTE   (Japan)

^b National Hospital Organization   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Isochromosome 17q; Myelodysplastic syndrome; Myeloid cell line

Indexed keywords

AGED; ARTICLE; BONE MARROW; CASE REPORT; CELL LINE; CHROMOSOME 17; CHROMOSOME ABERRATION; GENETICS; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PATHOLOGY; ULTRASTRUCTURE;

AGED; BONE MARROW; CELL LINE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES;

EID: 0031204741     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Koeffler HP: Myelodysplastic syndromes (Preleukemia). Semin Hematol (1986) 23, 284-299.
2. Carlo-Stella C, Cazzola M, Bergamaschi G, Bernasconi P, Dezza L, Invernizzi R and Pedrazzoli P: Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia (1989) 3, 363-366.
3. Zoumbos N, Symeonidis A, Kourakli A, Katevas P, Matsouka P, Perraki M and Georgoulias V: Increased levels of soluble interluekin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes. Blood (1991) 77, 413-414.
4. Hirai H, Kobayashi Y, Mano H, Hagiwara K, Maru Y, Omine M, Mizoguchi H, Nishida J and Takaku F: A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature (1987) 327, 430-432.
5. Ridge SA, Worwood M, Oscier D, Jacobs A and Padua RA: FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc Natl Acad Sci USA (1990) 87, 1377-1380.
6. Adamson DJA, Dawson AA, Bennett B, King DJ and Haites NE: p53 mutation in the myelodysplastic syndromes. Br J Haematol (1995) 89, 61-66.
7. 1-negative leukemia: A clinical, cytogenetic, and molecular study. Blood (1990) 75, 1679-1683.
8. Sole F, Torrabadella M, Granada I, Florensa L, Vallespi T, Ribera JM, Irriguible D, Milla F and Woessner S: Isochromosome 17q as a sole anomaly: A distinct myelodysplastic syndrome entity? Leuk Res (1993) 17, 717-720.
9. Takahashi I, Togitani K, Yokoyama M, Aita T, Makihata K, Sunami K, Shiromoto M, Nakamura T, Kawada I, Nishimura M, Nakada H, Yorimitsu S, Miyake S. Machida K and Kubonishi I: Refractory anemia with an excess of blasts developed into overt leukemia with leukothrombocytosis. Intern Med (1995) 34, 28-31.
10. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 65, 55-63.
11. Nagai M, Seki S, Kitahara T, Abe T, Minato K, Watanabe S and Shimoyama M: A novel human myelomonocytoid cell line, p39/ Tsugane, derived from overt leukemia following myelodysplastic syndrome. Gann (1984) 75, 1100-1107.
12. McCarty TM, Rajaraman S, Elder FFB, Gadson P and Thompson EB: Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome. Blood (1987) 70, 1665-1672.
13. Tohyama K, Tsutani H, Ueda T, Nakamura T and Yoshida Y: Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome. Br J Haematol (1994) 87, 235-242.
14. Caligaris-Cappio F, Bergui L, Rege-Cambrin G, Tesio L, Migone N and Malavasi F: Phenotypic, cytogenetic and molecular characterization of a new B-chronic lymphocytic leukemia (B-CLL) cell line. Leuk Res (1987) 11, 579-588.
15. Kelman Z, Prokocimer M, Peller S, Kahn Y, Rechavi G, Manor Y, Cohen A and Rotter V: Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood (1989) 74, 2318-2324.
16. Mashal R, Shtalrid M, Talpaz M, Kantarjian H, Smith L, Beran M, Cork A, Trujillo J, Gutterman J and Deisseroth A: Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood (1990) 75, 180-189.
17. Jonveaux P, Fenaux P, Quiquandon I, Pignon JM, Lai JL, Loucheux- Lefebvre MH, Goossens M, Bauters F and Berger R: Mutations in the p53 gene in myelodysplastic syndromes. Oncogene (1991) 6, 2243-2247.
18. Fenaux P, Jonveaux P, Quiquandon I, Lai JL, Pignon JM, Loucheux-Lefebvre MH, Bauters F, Berger R and Kerckaert JP: p53 gene mutations in acute myeloid leukemia with I7p monosomy. Blood (1991) 78, 1652-1657.
19. 1-positive or -negative myeloid leukemia. Leuk Res (1993) 17, 533-539.